Of note, despite all tested multiple myeloma cell lines being negative for t(11;14), we found that co-administration of ABT-199 (Venetoclax) with Kv1.3 inhibitors has a strong synergistic effect. The gene discussed is KCNA3; the disease is AL amyloidosis.